Resultado de búsqueda
Join us on our mission to improve global health by developing the next generation of immunotherapies and vaccines. BioNTech is growing - and this creates a lot of career opportunities in research, development, operations, commercial roles and enabling functions. Learn more about our culture, benefits and locations and find the right job for you.
The rapid development of our COVID-19 vaccine was only possible because we were able to build on the research, expertise and technology that we have accumulated over decades. BioNTech was founded on the idea of using mRNA to activate the immune system against a patient’s individual tumor – an approach that we believe can also be tailored to ...
Based in Cambridge, MA, BioNTech US serves as BioNTech’s North American headquarters and is an important part of our global effort to pioneer the development of next-generation immuno-oncology therapies. BioNTech US is a fully integrated subsidiary with a strong foundation in Europe and a focus on the development of novel neoantigen-targeted ...
29 de jul. de 2020 · Some of the authors have securities from BioNTech. Additional information Peer review information Nature thanks Thomas Tueting and the other, anonymous, reviewer(s) for their contribution to the ...
BioNTech SE An der Goldgrube 12 55131 Mainz, Germany. T: +49 6131 9084-0 F: +49 6131 9084-2121 M: ...
La vacuna de Pfizer-BioNTech contra la COVID-19, cuyo nombre comercial es Comirnaty 1 ( DCI: Tozinamerán, de nombre en clave inicial BNT162b2 ), 2 es una vacuna contra la COVID-19 basada en ARN mensajero. 3 La empresa alemana de biotecnología BioNTech es la desarrolladora original de la tecnología de vacunas, mientras que la empresa ...
El prospecto de Comirnaty, la vacuna de Pfizer/BioNTech, puede consultarse en el Centro de Información de Medicamentos (CIMA) de la Agencia Española de Medicamentos y Productos Sanitarios. Sobre la notificación de efectos adversos de las vacunas, pueden ser consultados los informes periódicos de farmacovigilancia.
